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Fig. A, Unadjusted outcomes and costs of endovascular aneurysm
repair (EVAR): 2000 to 2011. B, Adjusted outcomes and costs of
EVAR: 2009 to 2011 vs 2000 to 2002. CI, Conﬁdence interval; OR,
odds ratio.
JOURNAL OF VASCULAR SURGERY
832 Abstracts September 2014Methods: We identiﬁed 173 patients with PVR in a prospective data-
base of 6522 patients who underwent pancreatic resection at our hospital
from 1970 to 2014. A total of 128 patients had >6 months follow-up
with computed tomography imaging. Preoperative, intraoperative, and
postoperative factors were recorded. Patients with and without postopera-
tive PVR thrombosis were compared using univariate, multivariate, and
receiver-operating characteristic curve analyses.
Results: Patient survival was 100% at 1 month, 95% at 6 months,
83% at 1 year, and 54% on overall median follow-up of 194 days. Me-
dian survival was 14 6 26 months. Eighty-two percent of PVRs were
performed with a primary repair, 8.5% with interposition vein, 5.5%
with interposition prosthetic graft, and 4% with patch. PVR patency
was 100% at 1 day, 98% at 1 month, 91% at 6 months, and 83% at
1 year. Patients with PVR thrombosis were not signiﬁcantly different
from patients with a patent PVR in age, survival, preoperative comor-
bidities, tumor characteristics, perioperative blood loss or transfusion,
or postoperative complications. They were more likely to have preop-
erative chemotherapy (53% vs 9%, P ¼ .0001), radiation (35% vs 2%,
P ¼ .0001), prolonged operative time (610 6 91 vs 423 6 188 mi-
nutes, P ¼ .0001), and develop postoperative ascites (76% vs 22%,
P ¼ .0001). The number of patients who developed ascites in the
setting of tumor recurrence did not differ among those with throm-
bosed and patent PVR (38% vs 50%, P ¼ .7). Patients with PVR
thrombosis were more likely to have prosthetic graft placement than
patients with a patent PVR (18% vs 2.7%; odds ratio [OR], 7.7;
95% conﬁdence interval [CI], 1.4-42, P ¼ .03). PVR patency at
6 months was signiﬁcantly lower for graft reconstruction (0%)
compared with primary repair (95%, P ¼ .0004) and vein reconstruc-
tion (91%, P ¼ .04). On multivariate analysis, operative time (OR,
1.01; 95% CI, 1.01-1.02) and prosthetic graft placement (OR, 8.12;
95% CI, 1.1-74) were independent predictors of PVR thrombosis
(C statistic ¼ 0.88).
Conclusions: Long operative times and use of prosthetic grafts for
reconstruction are risk factors for postoperative portal vein thrombosis. Pri-
mary repair and vein interposition should be preferentially used for PVR in
the setting of pancreatic resection.
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Objectives: Early ﬁstula thrombosis (EFT) is a cause of autogenous
arteriovenous ﬁstula (AVF) failure. We followed up a cohort of men and
women with newly created AVFs to identify baseline predictors of EFT.
Methods: Cases of EFT, deﬁned as thrombosis diagnosed by physical
examination or ultrasound imaging, that occurred #16 days of AVF crea-
tion among participants of the Hemodialysis Fistula Maturation (HFM)
Study were compared with 166 non-EFT controls selected from the study.
They were optimally matched on ﬁve prespeciﬁed variables: gender, age (6
8 years), diabetes, dialysis status, and surgeon AVF volume within the prior
3 years (6 70 cases). Conditional logistic regression models were ﬁt with
and without adjustment for use of oral antithrombotic medication at
enrollment.
Results: Twenty-nine cases (5.3%) of EFT occurred among the ﬁrst
544 participants of a targeted enrollment of 600. Of the factors consid-
ered, the surgeon’s intraoperative perceptions were most strongly associ-
ated with EFT: maturation success (unlikely, marginal, likely) per
category (odds ratio [OR], 9.71; conﬁdence interval [CI], 3.7-25.5;yNew England Society for Vascular SurgeryP < .0001); absence vs presence of any intraoperative thrill (OR, 36.5;
CI, 4.2-320; P ¼ .0006); and the surgeon’s subjective frustration during
the procedure (OR, 6.99; CI, 2.38-20.5; P ¼ .0002). Longer duration
of surgery, which in both full and matched data sets was associated
with absence of thrill (2.0 vs 1.6 hours in the full data set), frustration
(2.3 vs 1.6 hours), and lower predicted likelihood of success (2.3 vs
1.7 vs 1.6 hours), was also itself predictive of EFT (OR, 2.0 per hour;
CI, 1.1-3.4; P ¼ .013). When present, a reduced extent of intraoperative
thrill (to the proximal, middle, or distal third of forearm/arm from the
ﬁstula) was also associated with EFT (OR per third of forearm/arm,
3.87; CI, 1.16-12.9; P ¼ .014). An intraoperative assessment that matu-
ration success was unlikely or that it was marginal when also combined
with surgeon frustration predicted 48% of EFTs with 98% speciﬁcity,
positive predictive value of 54%, and negative predictive value of 97%.
EFT was associated with forearm (vs upper arm) AVF (OR, 2.83; CI,
1.05-7.61; P ¼ .04). Oral antithrombotic medication was not signiﬁ-
cantly associated with EFT.
Conclusions: Although EFT was infrequent among HFM Study
participants, this outcome was common when the surgeon expressed
substantial intraoperative concern.
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Objectives: The purpose of this study was to characterize the
evolution in the “value” of endovascular abdominal aortic aneurysm
repair (EVAR) by detailing changes in adjusted outcomes and costs
over time.>Eastern Vascular Society
